New results from the Dutch-Belgian Randomized Lung Cancer Screening (NELSON) trial have reaffirmed that CT lung cancer screening can significantly reduce mortality for high-risk smokers, producing a 26% mortality reduction in men, according to a Tuesday presentation at the 2018 World Conference on Lung Cancer in Toronto.

Source: CT lung screening reduces cancer mortality in men by 26%